Stay updated on PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial
Sign up to get notified when there's something new on the PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial page.

Latest updates to the PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page displays Revision: v3.3.4, replacing the previous v3.3.3. This is a metadata update and does not change the study details, eligibility criteria, or results.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedFooter text updated: Revision: v3.3.3 added; HHS Vulnerability Disclosure and Revision: v3.3.2 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision: v3.3.2 is now displayed in the page footer, replacing v3.2.0. There are no changes to study content, eligibility criteria, endpoints, or other substantive content.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page footer-wide government funding/operating status notice has been removed, and this does not affect the trial details shown.SummaryDifference0.4%

- Check73 days agoChange DetectedNo additions or deletions were detected; core study details and layout remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check102 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference4%

Stay in the know with updates to PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial page.